vimarsana.com

Page 101 - பரிமாற்றம் வர்த்தகம் செய்யப்பட்டது நிதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

As Copper Prices Recover, COPX Can Capture Even More Upside

March 17, 2021 The ‘reopening’ trade isn’t just relegated to strength in equities as the economy recovers. Copper prices are also rising, and ETF investors can capture the forthcoming upside with the ”The narrative we’ve been hearing is that it’s really a play on the broader reopening of the economy,” says Spencer Barnes, associate vice-president of mutual fund and ETF strategy at Raymond James Ltd., in a The Globe and Mail article. “Copper is cyclical and driven by market expansion, so it’s not surprising how it’s been bid up thanks to the massive push to reopen the economy, and the stimulus we’re seeing.”

TrueMark Investments on Why to Buy Into the Tech Dip

March 17, 2021 After the pandemic took hold in 2020, technology greatly expanded thanks to businesses relying on working from home strategies, along with biotech’s importance. A recent dip in tech stocks may cause concern for some. ETF Trends caught up with Michael Loukas, Principal & CEO of TrueMark Investments, who shared his thoughts on investors with a long-term horizon buying into this dip, along with other knowledge focused on the  Looking at the current adjusted world, when it comes to the market evolving in regards to tech, Loukas explains, “The global demand for tech will continue to skyrocket. Pandemic-related lockdowns certainly increased the intensity of the spotlight on certain tech segments, but the appetite for these technologies isn’t going to simply vanish as covid restrictions come to an end. We’ve been pounding the table on this for the better part of twelve months. The trends were already in place; the pandemic simply sped up the timeline.  As the w

Already Up 130%, This ETF Is Set to Soar Post-COVID

Already Up 130%, This ETF Is Set to Soar Post-COVID March 17, 2021 With coronavirus vaccinations increasing and many consumers flush with cash courtesy of Uncle Sam, reopening stocks are rallying. That’s good news for the PEJ is based on the Dynamic Leisure & Entertainment Intellidex℠ Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including: price momentum, earnings momentum, quality, management action, and value. The Index is comprised of common stocks of 30 US leisure and entertainment companies. The Invesco ETF is hot, jumping 8.45% over the past week.

Four Investing Styles, One Fund: The iShares EMGF ETF

Four Investing Styles, One Fund: The iShares EMGF ETF March 17, 2021 Emerging markets (EMs) can be a tricky endeavor, which is where adding a factor filter over EM investments can help. But which investment factor to go with? ETF investors can get four factors in one fund via the The fund seeks to track the investment results of the MSCI Emerging Markets Diversified Multiple-Factor Index. EMGF generally will invest at least 90% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index.

Synthetic Biology: What It Is and Why ARKG Is So Levered to It

ARKG includes companies that merge healthcare with technology to capitalize on the revolution in genomic sequencing. These companies try to better understand how biological information is collected, processed, and applied by reducing guesswork and enhancing precision, restructuring health care, agriculture, and pharmaceuticals in the process. As ARK research points out, yet another emerging opportunity within the genomics space is synthetic biology (SynBio). “Synthetic biology (SynBio) is a rapidly growing field of science that engineers organisms and biomolecules with novel properties not found in nature,” according to the issuer. “Central to SynBio is the ability to assemble DNA from its four canonical bases (A, T, G, and C), creating oligonucleotides or ‘oligos’, for many healthcare applications. Diagnosticians use synthetic oligos, for example, to calibrate and verify the performance of both PCR and sequencing-based tests for COVID-19.”

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.